Single-cell imaging of CAR T cell activity in vivo reveals extensive functional and anatomical heterogeneity.
Marine CazauxCapucine L GrandjeanFabrice LemaîtreZacarias GarciaRichard J BeckIdan MiloJérémy PostatJoost B BeltmanEleanor J CheadlePhilippe BoussoPublished in: The Journal of experimental medicine (2019)
CAR T cells represent a potentially curative strategy for B cell malignancies. However, the outcome and dynamics of CAR T cell interactions in distinct anatomical sites are poorly understood. Using intravital imaging, we tracked interactions established by anti-CD19 CAR T cells in B cell lymphoma-bearing mice. Circulating targets trapped CAR T cells in the lungs, reducing their access to lymphoid organs. In the bone marrow, tumor apoptosis was largely due to CAR T cells that engaged, killed, and detached from their targets within 25 min. Notably, not all CAR T cell contacts elicited calcium signaling or killing while interacting with tumors, uncovering extensive functional heterogeneity. Mathematical modeling revealed that direct killing was sufficient for tumor regression. Finally, antigen-loss variants emerged in the bone marrow, but not in lymph nodes, where CAR T cell cytotoxic activity was reduced. Our results identify a previously unappreciated level of diversity in the outcomes of CAR T cell interactions in vivo, with important clinical implications.
Keyphrases
- single cell
- bone marrow
- rna seq
- lymph node
- high resolution
- cell cycle arrest
- mesenchymal stem cells
- high throughput
- type diabetes
- diffuse large b cell lymphoma
- cell death
- copy number
- cell therapy
- cell proliferation
- early stage
- high fat diet induced
- rectal cancer
- weight loss
- genome wide
- insulin resistance
- fluorescence imaging